Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, CureVac N.V. (NASDAQ: CVAC) closed at $2.94 down -2.00% from its previous closing price of $3.00. In other words, the price has decreased by -$2.00 from its previous closing price. On the day, 0.4 million shares were traded. CVAC stock price reached its highest trading level at $3.11 during the session, while it also had its lowest trading level at $2.93.
Ratios:
For a deeper understanding of CureVac N.V.’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.28 and its Current Ratio is at 2.29. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Leerink Partners on April 25, 2024, Downgraded its rating to Market Perform and sets its target price to $4 from $12 previously.
On June 08, 2023, SVB Securities started tracking the stock assigning a Outperform rating and target price of $13.
UBS Upgraded its Neutral to Buy on January 19, 2023, whereas the target price for the stock was revised from $8 to $18.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 27 ’24 when Pierre Kemula bought 55 shares for $3.08 per share.
Pierre Kemula bought 34,000 shares of CVAC for $105,400 on Sep 25 ’24.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CVAC now has a Market Capitalization of 672942464 and an Enterprise Value of 496003200. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.27 while its Price-to-Book (P/B) ratio in mrq is 1.63. Its current Enterprise Value per Revenue stands at 7.531 whereas that against EBITDA is -1.835.
Stock Price History:
Over the past 52 weeks, CVAC has reached a high of $7.43, while it has fallen to a 52-week low of $2.21. The 50-Day Moving Average of the stock is -10.62%, while the 200-Day Moving Average is calculated to be -14.71%.
Shares Statistics:
For the past three months, CVAC has traded an average of 768.55K shares per day and 481190 over the past ten days. A total of 223.99M shares are outstanding, with a floating share count of 93.63M. Insiders hold about 58.26% of the company’s shares, while institutions hold 6.46% stake in the company. Shares short for CVAC as of 1726185600 were 5514775 with a Short Ratio of 7.18, compared to 1723680000 on 5646818. Therefore, it implies a Short% of Shares Outstanding of 5514775 and a Short% of Float of 13.76.
